[Levodopa and decarboxylase inhibitors in Parkinson's disease].
D000328:Adult; D000368:Aged; D001545:Benserazide / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D010300:Parkinson Disease / Q000188:drug therapy*; D014839:Vomiting / Q000139:chemically induced
D006834:Hydrazines; D007980:Levodopa; D001545:Benserazide
Levodopa och dekarboxylashämmare vid morbus Parkinson